10316827

Source:http://linkedlifedata.com/resource/pubmed/id/10316827

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0038137, umls-concept:C0085155, umls-concept:C0175675, umls-concept:C0592503, umls-concept:C1546805
pubmed:issue	4
pubmed:dateCreated	1979-7-28
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/1251744
pubmed:citationSubset	H
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Pharmaceutical Preparations
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0020-9546
pubmed:author	pubmed-author:LasagnaL CLC
pubmed:issnType	Print
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	11, 13
pubmed:dateRevised	2000-12-18
pubmed:meshHeading	pubmed-meshheading:10316827-Legislation, Drug, pubmed-meshheading:10316827-Pharmaceutical Preparations, pubmed-meshheading:10316827-Public Policy, pubmed-meshheading:10316827-Therapeutic Equivalency, pubmed-meshheading:10316827-United States, pubmed-meshheading:10316827-United States Food and Drug Administration
pubmed:year	1979
pubmed:articleTitle	Generic vs. brand name drugs--defining and enforcing standards.
pubmed:publicationType	Journal Article